The binding of COVID-19 and ACE2 seems to result in the exhaustion of ACE2, thus inhibiting the ACE2/Ang-(1-7)/Mas receptor pathway and altering the balance of the RAS, and this would lead to the exacerbation of acute severe pneumonia [48]. The gene discussed is ACE2; the disease is COVID-19.